18 tracked 13F filers disclose a position in ICU as of the latest SEC 13F filings, a combined $464K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | $182K | 50K | ▼−11% Reduced · −6K sh | Q2 2026 | |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $107K | 29K | →First observed position No prior filed position | Q1 2026 | |
| 3 | JANE STREET GROUP, LLC | $104K | 28K | ▼−78% Reduced · −99K sh | Q1 2026 | |
| 4 | VANGUARD FIDUCIARY TRUST CO | $51K | 14K | →First observed position No prior filed position | Q1 2026 | |
| 5 | PNC FINANCIAL SERVICES GROUP, INC. | $7K | 2K | ▼−90% Reduced · −16K sh | Q1 2026 | |
| 6 | Tower Research Capital LLC (TRC) | $5K | 1K | ▲New +1K sh | Q1 2026 | |
| 7 | BlackRock, Inc. | $3K | 913 | ▼−90% Reduced · −8K sh | Q1 2026 | |
| 8 | UBS Group AG | $3K | 793 | ▼−94% Reduced · −12K sh | Q1 2026 | |
| 9 | OSAIC HOLDINGS, INC. | $854 | 230 | ▼−90% Reduced · −2K sh | Q1 2026 | |
| 10 | NewEdge Advisors, LLC | $647 | 176 | —Held | Q2 2026 | |
| 11 | Vanguard Global Advisers, LLC | $614 | 165 | →First observed position No prior filed position | Q1 2026 | |
| 12 | TD Waterhouse Canada Inc. | $106 | 22 | —Held | Q2 2026 | |
| 13 | MORGAN STANLEY | $74 | 20 | ▼−90% Reduced · −180 sh | Q1 2026 | |
| 14 | SBI Securities Co., Ltd. | $51 | 14 | —Held | Q2 2026 | |
| 15 | SOA Wealth Advisors, LLC. | $22 | 6 | —Held | Q2 2026 | |
| 16 | Caitong International Asset Management Co., Ltd | $7 | 2 | ▲New +2 sh | Q2 2026 | |
| 17 | HighMark Wealth Management LLC | $7 | 2 | —Held | Q2 2026 | |
| 18 | CWM, LLC | $4 | 1 | —Held | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 2 funds opened a new position in ICU, while 0 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| NVIDIA CORPNVDA | 3 funds | $539.7M |
| APPLE INCAAPL | 3 funds | $273.9M |
| MICRON TECHNOLOGY INCMU | 3 funds | $220.3M |
| TESLA INCTSLA | 3 funds | $184.1M |
| ALPHABET INC-CL AGOOGL | 3 funds | $170.3M |
| AMAZON.COM INCAMZN | 3 funds | $123.8M |
| ALPHABET INC-CL CGOOG | 3 funds | $102.6M |
| ADVANCED MICRO DEVICESAMD | 3 funds | $91.2M |
| INTEL CORPINTC | 3 funds | $71.2M |
| BERKSHIRE HATHAWAY INC-CL BBRK/B | 3 funds | $52.3M |
| TAIWAN SEMICONDUCTOR-SP ADRTSM | 3 funds | $48.8M |
| JOHNSON & JOHNSONJNJ | 3 funds | $45.8M |
Ranked by how many of ICU's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Messinger Michael | Chief Financial Officer | Buy (P) | 750 | $2K |
| Dec 19, 2025 | Baird Jennifer A | Director | Buy (P) | 4K | $1K |
| Dec 9, 2025 | Messinger Michael | Chief Financial Officer | Buy (P) | 15K | $5K |
| Aug 27, 2025 | Van Heel Kenneth | Director | Buy (P) | 10K | $9K |
| Aug 26, 2025 | Van Heel Kenneth | Director | Buy (P) | 25K | $22K |
| Aug 22, 2025 | Chung Kevin | Chief Medical Officer | Buy (P) | 10K | $8K |
| Jun 30, 2025 | Baird Jennifer A | Director | Buy (P) | 10K | $4K |
| Jun 24, 2025 | Neuman John | Director | Buy (P) | 40K | $14K |
| May 20, 2025 | Chung Kevin | Chief Medical Officer | Buy (P) | 5K | $6K |
| May 20, 2025 | Baird Jennifer A | Director | Buy (P) | 10K | $13K |
| Dec 11, 2024 | Neuman John | Director | Buy (P) | 10K | $20K |
| Nov 18, 2024 | Chung Kevin | Chief Medical Officer | Buy (P) | 4K | $8K |
| Class | 13F holders | Value held |
|---|---|---|
| ICUthis pageStock | 18 funds | $464K |
| ICUCWWTS | 11 funds | $931K |
Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.
Connected entities for ICU
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ICU/capital-change-brief"
Use Arkolith's capital_change_brief for ICU. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ICU. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.